2016
DOI: 10.1111/eci.12652
|View full text |Cite
|
Sign up to set email alerts
|

Effect of endothelin‐1 and endothelin receptor blockade on the release of microparticles

Abstract: Our in vitro results suggest that ET-1 stimulates the release of EMP from HUVECs via a receptor-dependent mechanism. Co-incubation with an endothelin receptor blocker abolished ET-1-dependent EMP release. However, treatment with bosentan for 4 weeks failed to alter EMP levels in patients with T2DM. Other factors seem to have influenced EMP release in patients with T2DM independent of ET-1 receptor-mediated mechanisms.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
6
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 30 publications
(44 reference statements)
1
6
0
Order By: Relevance
“…Because activated endothelial cells increase expression of cell adhesion molecules, the reductions in shear may have increased uptake of endothelial MPs (Jansen et al., 2015). ET‐1 binding contributes to endothelial MP release in vitro (Jung et al., 2016), and has been proposed as a contributor to the sitting‐induced vasculopathy (Padilla & Fadel, 2017). However, we observed no changes in ET‐1 after sitting, with or without calf raises, which conflicts with previous reports showing consistent rises during prolonged sitting (Ballard et al., 2017).…”
Section: Discussionmentioning
confidence: 99%
“…Because activated endothelial cells increase expression of cell adhesion molecules, the reductions in shear may have increased uptake of endothelial MPs (Jansen et al., 2015). ET‐1 binding contributes to endothelial MP release in vitro (Jung et al., 2016), and has been proposed as a contributor to the sitting‐induced vasculopathy (Padilla & Fadel, 2017). However, we observed no changes in ET‐1 after sitting, with or without calf raises, which conflicts with previous reports showing consistent rises during prolonged sitting (Ballard et al., 2017).…”
Section: Discussionmentioning
confidence: 99%
“…However, in patients with diabetes, bosentan did not affect EMP levels. 85 Recently, we have determined that staying at 2978 m above sea level resulted in a significant decrease of EMP levels. Still, the additional intake of the endothelin receptor blocker Macitentan did not influence EMP concentrations nor cardiovascular biomarkers.…”
Section: Effect Of Endothelin-1 and Endothelin Receptor Blockade Onmentioning
confidence: 99%
“…Microparticles are defined as small phospholipid vesicles without a nucleus that are released from different cells, platelets, erythrocytes, leukocytes and endothelial cells [17–19]. Endothelial cell microparticles (EMP) can be identified by antigens expressed by mature endothelial cells such as CD31 [20].…”
Section: Introductionmentioning
confidence: 99%